Search Results

Zika virus diversity in mice is maintained during early vertical transmission from placenta to fetus, but reduced in fetal bodies and brains at late stages of infection.

• Authors : Evans AB; Laboratory of Neurological Infections and Immunity, Neuroimmunology Section; Rocky Mountain Laboratories

Subjects: Zika Virus*/Zika Virus*/Zika Virus*/genetics ; Zika Virus Infection* ; Pregnancy Complications, Infectious*

• Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Oct 05; Vol. 17 (10), pp. e0011657. Date of Electronic Publication: 2023 Oct 05 (Print Publication: 2023).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet

Record details

N 4 -Hydroxycytidine/Molnupiravir Inhibits RNA-Virus Induced Encephalitis by Producing Mutated Viruses with Reduced Fitness.

• Authors : Ojha D; Hill CS; Zhou S

• Source: BioRxiv : the preprint server for biology [bioRxiv] 2023 Aug 23. Date of Electronic Publication: 2023 Aug 23.Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not

Record details

Activating the 'peerness' of youth leaders in a community sports programme through techne and phronesis.

• Authors : Christensen JH; Department of Nutrition, Exercise and Sports, University of Copenhagen, Nørre Allé 51, 2200 Copenhagen N, Denmark.; GAME, Enghavevej 82D, 2450 Copenhagen SV, Denmark.

Subjects: Peer Group* ; Sports*; Adolescent

• Source: Health promotion international [Health Promot Int] 2022 Dec 01; Vol. 37 (6).Publisher: Oxford University Press Country of Publication: England NLM ID: 9008939 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines.

• Authors : Elliott T; Department of Infectious Disease, Imperial College London, United Kingdom.; Imperial College Healthcare NHS Trust, London, United Kingdom.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19 Vaccines*; Antibodies, Neutralizing SARS-CoV-2 variants

• Source: PLoS pathogens [PLoS Pathog] 2022 Oct 04; Vol. 18 (10), pp. e1010885. Date of Electronic Publication: 2022 Oct 04 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Differences in neuroinvasion and protective innate immune pathways between encephalitic California Serogroup orthobunyaviruses.

• Authors : Evans AB; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.; Winkler CW

Subjects: Encephalitis Virus, California*/Encephalitis Virus, California*/Encephalitis Virus, California*/genetics ; Encephalitis, California* ; Orthobunyavirus*/Orthobunyavirus*/Orthobunyavirus*/genetics

• Source: PLoS pathogens [PLoS Pathog] 2022 Mar 04; Vol. 18 (3), pp. e1010384. Date of Electronic Publication: 2022 Mar 04 (Print Publication: 2022).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet

Record details

Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy.

• Authors : Taha Y; Department of Infectious Diseases and Tropical Medicine, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.; Microbiology and Virology Department, Laboratory Medicine Directorate, The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Subjects: COVID-19 Drug Treatment*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use ; Persistent Infection/Persistent Infection/Persistent Infection/*virologySARS-CoV-2 variants

• Source: Annals of clinical microbiology and antimicrobials [Ann Clin Microbiol Antimicrob] 2021 Dec 30; Vol. 20 (1), pp. 85. Date of Electronic Publication: 2021 Dec 30.Publisher: BioMed Central Country of Publication: England NLM ID: 101152152 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-0711

Record details

Cross reactivity of neutralizing antibodies to the encephalitic California Serogroup orthobunyaviruses varies by virus and genetic relatedness.

• Authors : Evans AB; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA.; Peterson KE

Subjects: Cross Reactions*; Antibodies, Neutralizing/Antibodies, Neutralizing/Antibodies, Neutralizing/*immunology ; Antibodies, Viral/Antibodies, Viral/Antibodies, Viral/*immunology

• Source: Scientific reports [Sci Rep] 2021 Aug 12; Vol. 11 (1), pp. 16424. Date of Electronic Publication: 2021 Aug 12.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Placental Myeloid Cells Protect against Zika Virus Vertical Transmission in a Rag1 -Deficient Mouse Model.

• Authors : Winkler CW; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840; and.

Subjects: Infectious Disease Transmission, Vertical*; Macrophages/Macrophages/Macrophages/*immunology ; Monocytes/Monocytes/Monocytes/*immunology

• Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2020 Jul 01; Vol. 205 (1), pp. 143-152. Date of Electronic Publication: 2020 Jun 03.Publisher: American Association of Immunologists Country of Publication: United States NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium:

Record details

Throw out the Map: Neuropathogenesis of the Globally Expanding California Serogroup of Orthobunyaviruses.

• Authors : Evans AB; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA. .; Peterson KE

Subjects: Encephalitis Virus, California/Encephalitis Virus, California/Encephalitis Virus, California/*physiology ; Encephalitis, California/Encephalitis, California/Encephalitis, California/*transmission ; Encephalitis, California/Encephalitis, California/Encephalitis, California/*virology

• Source: Viruses [Viruses] 2019 Aug 29; Vol. 11 (9). Date of Electronic Publication: 2019 Aug 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Copenhagen Consensus statement 2019: physical activity and ageing.

• Authors : Bangsbo J; Department of Nutrition Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.; Blackwell J

Subjects: Cognition/Cognition/Cognition/*physiology ; Exercise/Exercise/Exercise/*physiology ; Healthy Aging/Healthy Aging/Healthy Aging/*physiology

• Source: British journal of sports medicine [Br J Sports Med] 2019 Jul; Vol. 53 (14), pp. 856-858. Date of Electronic Publication: 2019 Feb 21.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 0432520 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details